Introduction
The effects of high doses of oestradiol benzoate administered to intact adult male rats for 1 day , or daily for 28 or 40 (Kind et al, 1965) days have been described. Tcholakian etal (1974) demonstrated that a single subcutaneous (s.c.) injection of 50 µg inhibited testosterone production within a few hours and that about 6 days were required before the testes recovered their normal steroidogenic function (Tchola¬ kian, Chowdhury & Chowdhury, 1978) . Chronic daily treatment for 2 weeks produced atrophy of the testes and accessory sex organs (Chowdhury & Steinberger, 1975 ; Tcholakian et al, 1978) , decreased plasma and testicular testosterone concentrations and significantly reduced pituitary LH concen¬ tration. These suppressive effects on the testis and pituitary persisted for 60 days after cessation of treatment. One attempt to speed the recovery of oestrogen-'damaged' testes by acute treatment with exogenous LH indicated that, although LH (1-100 µg/rat) significantly elevated serum testosterone levels in oestrogen-treated and control rats, those in the treated animals were significantly lower than in the control animals (Moger, 1976) .
The recent availability of an analogue of LH-RH which has intense and prolonged gonadotrophinreleasing activities in the rat in vivo (Vilchez-Martinez et al, 1974; de la Cruz et al, 1975) and in vitro (Coy, Labrie, Savary, Coy & Schally, 1976) has led us to investigate its ability to speed the recovery of testicular function in rats treated with oestradiol benzoate.
Materials and Methods
The studies were performed on 90-day-old Long-Evans rats, raised in our colony in a controlled temperature (21 ± 1°C) and light (12 h light/24 h) environment. The animals were allowed free access to food and water throughout the experiment. 
Assays
Gonadotrophins. Serum LH and FSH were measured by a double-antibody radioimmunoassay with reagents provided by the National Pituitary Agency as described elsewhere (Chowdhury & Steinberger, 1976) . Rat-FSH-RPl (21 NIH-FSH-S1)and rat-LH-RPl (003 NIH-LH-S1) were used as reference standards. The minimum sensitivity of the assay was 12-5 ng/tube for FSH and 3 ng/tube for LH, with a mean intra-assay variation of 4-5 % for FSH and 3-3 % for LH. All deter¬ minations were performed in a single assay, 1 point per sample of 01 ml volume with a correlation coefficient of-0-996 for LH and -0-986 for FSH.
Testosterone. A radioligand immunoassay was used for determination of plasma and testicular concentrations . The antibody was raised in rabbits against a 19-carboxymethyloxime ether derivative of testosterone conjugated to bovine serum albumin (Rao, Moore, Peterson & Tcholakian, 1978) . The antiserum cross-reacted with other steroids as follows: testo¬ sterone, 100%; 5a-dihydrotostesterone, 6-65 %; 5a-androstane-3a,17ß-diol, 2-2%; all other steroids, 0-< 1 %. All samples were measured in a single assay with an intra-assay variation of 6% and a sensitivity of 0-2 ng/ml plasma. Statistical (Table 2) . Values for rats in Groups and C were not significantly different from those of normal untreated rats in Group A (Table 2 ).
Discussion
The effects in male rats of daily administration of oestradiol benzoate for 21 days on body weight, pituitary, testicular and accessory sex organ weights and on serum gonadotrophins and plasma and testicular concentrations of testosterone in this study agree with previous reports on its effects in adult male rats treated daily for 14 days , 28 days or 40 days (Kind et al, 1965) . The suppressive effect of oestradiol benzoate on thegonado-pituitary axis appears to be due to (1 ) the direct effect of oestrogens on the testes, possibly via suppression of steroid enzymes concerned with testosterone synthesis (Samuels, Short & Huseby, 1964; Oshima, Wakabayashi & Tamaoki, 1967; Moger, 1976; Kremers, Tixhon &Grielen, 1977) , and (2) the suppression of pituitary gonadotrophins which regulate androgen synthesis (Bogdanove, Diebel, Story & Kingsley, 1971; Tcholakian et al, 1978) .
The recovery patterns of testosterone and gonadotrophins seem to indicate that oestradiol benzoate may act independently on the testes and the pituitary because the testes recover to control levels earlierthan does the pituitary . In the present study most of thesuppressive effects of oestradiol benzoate were diminished by 30 days after the end of treatment except that serum LH levels remained significantly low. The significant (P < 0005) elevation in the circulating levels of both gonadotrophins caused by 200 ng{D-Leu6,des-Gly-NH210}-LH-RH-ethylamideisadirect activity ofthe analogue that overcame the suppressive effects of oestradiol benzoate, indicating a strong gonadotrophin-releasing activity of this analogue in male rats. Asingledose of 50nganalogue maintained elevated serum LH and FSH levels for up to 6 h after administration (Vilchez-Martinez, Pedroza, Coy, Arimura & Schally, 1977 . It has been suggested that chronic treatment with oestradiol benzoate may produce a long-term effect on the ability of the testes to respond to endogenous or exogenous LH (Samuels et al, 1964; Tcholakian et al, 1978) . Our present data support this suggestion.
It is probable that the LH-RH analogue has a direct inhibitory effect on testicular steroidogenesis in addition to stimulating gonadotrophin secretion. Recent observations that synthetic LH-RH and its superactive analogues may have a direct suppressive action on the ovary and uterus of rats (Johnson, Gendrick & White, 1976; Rippel & Johnson, 1976 
